Co-occurring mutations in TET2, IDH1, IDH2 and SRSF2 were linked to the development of systemic inflammatory and autoimmune diseases, some of which are also present in MDS patients (39). This evidence concerns the gene SRSF2 and myelodysplastic syndrome.